Document is current
Any future updates will be listed below
-
Authors
Moreira, Ryan https://orcid.org/0000-0003-0694-219X
Chakraborty, Bidisha https://orcid.org/0000-0001-6896-2423
Yang, Yi https://orcid.org/0009-0009-7467-0641
Padhi, Chandrashekhar https://orcid.org/0009-0009-1305-0377
Gilmore, Michael S. https://orcid.org/0000-0001-6389-832X
Nair, Satish K. https://orcid.org/0000-0003-1790-1334
van der Donk, Wilfred A. https://orcid.org/0000-0002-5467-7071
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Research Resources (S10 RR027109 A)
Howard Hughes Medical Institute
Life Sciences Research Foundation
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM151874)
- License Information
-
More Information
Article History
Received: 27 December 2024
Accepted: 11 July 2025
First Online: 28 July 2025
Competing interests
: The University of Illinois has filed a provisional patent application on the work described in this study: van der Donk, W.A.; Moreira, R.; Chakraborty, B.; Nair, S.K.; “INHIBITION OF GUT BACTERIA” U.S. Patent Application No. 63/779,530. Filed March 28, 2025. This application covers CylA as target for therapeutic intervention.
